77 related articles for article (PubMed ID: 2907712)
1. Effect of an original piperazine derivative of tetraline on the adrenergically mediated metabolic responses in cats and rats.
Bogoslovova T; Staneva-Stoytcheva D
Acta Physiol Pharmacol Bulg; 1988; 14(4):55-64. PubMed ID: 2907712
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenoblocking activity of a new derivative of 2-aminotetraline based on some metabolic responses in cats and rats.
Bogoslovova T; Staneva-Stoytcheva D
Acta Physiol Pharmacol Bulg; 1988; 14(3):39-45. PubMed ID: 2906208
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new 2-piperazinotetralin on alpha-1 and alpha-2 adrenergic receptors in isolated rat vas deferens.
Mutafova-Yambolieva V; Staneva-Stoytcheva D; Ivanov D
Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):291-6. PubMed ID: 2997557
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
Maruyama Y; Awaji T; Inoue M; Takeo S
Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392
[TBL] [Abstract][Full Text] [Related]
5. [Hypotensive and antihypertensive activity of a newly synthesized derivative of 2-aminotetralin].
Raĭnova L; Georgieva A; Staneva-Stoĭcheva D
Eksp Med Morfol; 1978; 17(1):37-43. PubMed ID: 25170
[TBL] [Abstract][Full Text] [Related]
6. Effect of catecholamines and adrenergic antagonists on blood glucose, free fatty acids and liver glycogen levels in fed rats.
Bugajski J; Hano J; Zdebska A
Pol J Pharmacol Pharm; 1978; 30(6):799-818. PubMed ID: 755244
[TBL] [Abstract][Full Text] [Related]
7. Effect of one derivative of 2-aminotetralin on the alpha-adrenergic receptors of isolated vessels.
Mutafova-Yambolieva V; Staneva-Stoytcheva D
Acta Physiol Pharmacol Bulg; 1985; 11(1):18-25. PubMed ID: 2994366
[TBL] [Abstract][Full Text] [Related]
8. [Biochemical studies of acebutolol-the beta1 specificity of acebutolol (author's transl)].
Hamada Y; Sato I; Ito K; Kuwabara S; Kojima Y
Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):591-6. PubMed ID: 21835
[TBL] [Abstract][Full Text] [Related]
9. [Influence of alpha or beta adrenergic antagonists on catecholamine dependent metabolic effects in pigs].
Brenner KV; Gürtler H
Acta Biol Med Ger; 1981; 40(12):1759-66. PubMed ID: 6125073
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
Nishimura T; Kita S; Abiko Y
J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and physiological effects of adrenoceptor agonists and antagonists in the horse.
Snow DH
Res Vet Sci; 1979 Nov; 27(3):372-8. PubMed ID: 44381
[TBL] [Abstract][Full Text] [Related]
12. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
13. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
[TBL] [Abstract][Full Text] [Related]
14. Examinations of contribution of bradykinin in the action of dopamine in circulatory system of rats. III. Influence of bradykinin on chosen metabolic effects of dopamine.
Fiedorowicz R; Moniuszko-Jakoniuk J; Wiśniewski K
Arch Immunol Ther Exp (Warsz); 1983; 31(5):761-8. PubMed ID: 6675576
[TBL] [Abstract][Full Text] [Related]
15. Interactions between sympathomimetic agonists and blocking agents: cardiac effects of phenylephrine and isoproterenol.
Márquez MT; Mikulić LE; Aramendía P
Methods Find Exp Clin Pharmacol; 1981; 3(5):283-9. PubMed ID: 7329156
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of various beta-adrenoceptor blocking agents in rats and dogs.
Traunecker W
Arzneimittelforschung; 1985; 35(1A):376-82. PubMed ID: 2859032
[TBL] [Abstract][Full Text] [Related]
17. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
Chen J; Zhang LF; Han C; Yu GS; Ma J
J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
[TBL] [Abstract][Full Text] [Related]
18. [Adrenergic mechanisms in the hypotensive action of a piperazine derivative of 2-aminotetralin].
Mutafova-Iambolieva V; Staneva-Stoĭcheva D
Eksp Med Morfol; 1985; 24(1):8-12. PubMed ID: 2992908
[No Abstract] [Full Text] [Related]
19. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
